Today in News History
On July 12, several notable moments in the history of News stand out. In 1849, William Osler, Canadian physician and author (died 1919) was born. In 1920, Pierre Berton, Canadian journalist and author (died 2004) was born. In 1935, Satoshi Ōmura, Japanese biochemist and academic, Nobel Prize laureate was born. In 1967, Bruny Surin, Canadian sprinter was born. In 1985, Keven Lacombe, Canadian cyclist was born. In 2000, Charles Merritt, Canadian colonel and politician, Victoria Cross recipient (born 1908) passed away. In 2006, The 2006 Lebanon War begins. In 2013, Amar Bose, American businessman, founded the Bose Corporation (born 1929) passed away. In 2014, Jamil Ahmad, Pakistani author (born 1931) passed away. In 2024, Evan Wright, American writer (born 1964) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.
Axsome Therapeutics, Exelixis, Incyte Among 20 New Stocks On IBD's Premier Watchlists
IBD’s top-performing stock lists have just been updated. See which stocks got added – and which got cut. The post Axsome Therapeutics, Exelixis, Incyte Among 20 New Stocks On IBD's Premier Watchlists appeared first on Investor's Business Daily.
Narrative Intelligence Brief
This article was published by Investors Business Daily, a source frequently categorized with a right bias based in United States of America. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of Investors Business Daily, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.
More from Investors Business Daily
July 7, 2026
Chip Sell-Off Hits Nasdaq As Stock Market Uptrend Wobbles; Sandisk, Intel Give Sell Signals
July 7, 2026
Dow Jones Futures Tumble, Oil Prices Soar As Trump Says U.S.-Iran Ceasefire 'Over'
July 7, 2026
Dow Jones Payments Leader Visa Breaks Out; Arista Networks Eyes Buy Point
July 7, 2026
IBD Live Q&A And Two Key Stock Lists For July 7, 2026
July 7, 2026
This European Stock Market Quietly Becomes A Regional Leader To Watch
Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.More Coverage
Discussion
"lindsey graham"
How other outlets are covering this story
Compare narratives across 6 related reports from 6 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.
Coverage bias distribution
6 sources
Left 17%
Center 33%
Right 50%
Seeking Alpha
· Jul 2, 2026
Ascendis Pharma: Behind The Stock Surge
Ascendis Pharma: Behind The Stock Surge
The Motley Fool
· Jun 29, 2026
Nuvation Bio Stock Is Up 190% Despite Recent Pressure. Should Investors Care About This $753,000 Insider Sale?
This oncology biotech advancing targeted therapies reported a notable insider sale amid ongoing clinical-stage development.
Medical Daily
· Jul 1, 2026
Duloxetine (Generic Cymbalta) Recalled Over Potential Cancer-Causing Compound: Here Are the Lot Numbers to Check
Duloxetine (generic Cymbalta) has been recalled by Breckenridge Pharmaceutical for elevated nitrosamine levels. Here are the specific lot numbers and the critical safety warning.
The Wall Street Journal - Business
· Jun 22, 2026
AbbVie to Buy Apogee Therapeutics for $10.9 Billion in Cash
AbbVie has agreed to buy Apogee Therapeutics for about 10.9 billion in cash in a deal that bolsters the biopharmaceutical company’s immunology and inflammation portfolio.
The Hindu BusinessLine
· Jun 26, 2026
Lupin gets tentative US FDA nod for Enzalutamide tablets
The US FDA has tentatively approved Lupin’s Enzalutamide Tablets in 40 mg and 80 mg as bioequivalent to Astellas’ Xtandi Tablets for the approved indication
Investing.com
· Jun 22, 2026
Form 4 Aeon Biopharma Inc For: 22 June
Form 4 Aeon Biopharma Inc For: 22 June
Topics:
Related coverage for "Axsome Therapeutics, Exelixis, Incyte Among 20 New Stocks On IBD's Premier Watchlists": Seeking Alpha — Ascendis Pharma: Behind The Stock Surge. The Motley Fool — Nuvation Bio Stock Is Up 190% Despite Recent Pressure. Should Investors Care About This $753,000 Insider Sale?. Medical Daily — Duloxetine (Generic Cymbalta) Recalled Over Potential Cancer-Causing Compound: Here Are the Lot Numbers to Check. The Wall Street Journal - Business — AbbVie to Buy Apogee Therapeutics for $10.9 Billion in Cash. The Hindu BusinessLine — Lupin gets tentative US FDA nod for Enzalutamide tablets. Investing.com — Form 4 Aeon Biopharma Inc For: 22 June